Cover Page - USD ($) $ in Billions | 12 Months Ended | | |
Dec. 31, 2021 | Apr. 10, 2022 | Jun. 30, 2021 |
Cover [Abstract] | | | |
Document Type | 10-K/A | | |
Amendment Flag | true | | |
Document Period End Date | Dec. 31, 2021 | | |
Document Fiscal Year Focus | 2021 | | |
Document Fiscal Period Focus | FY | | |
Document Transition Report | false | | |
Entity Registrant Name | ORGANOGENESIS HOLDINGS INC. | | |
Entity Central Index Key | 0001661181 | | |
Current Fiscal Year End Date | --12-31 | | |
Entity Filer Category | Large Accelerated Filer | | |
Entity Well-known Seasoned Issuer | No | | |
Entity Voluntary Filers | No | | |
Entity Current Reporting Status | Yes | | |
Entity Interactive Data Current | Yes | | |
Entity Public Float | | | $ 1.1 |
Trading Symbol | ORGO | | |
Entity Small Business | false | | |
Entity Emerging Growth Company | false | | |
Entity Shell Company | false | | |
Entity Address, State or Province | MA | | |
Title of 12(b) Security | Class A Common Stock, $0.0001 par value | | |
Security Exchange Name | NASDAQ | | |
Document Annual Report | true | | |
Entity Common Stock, Shares Outstanding | | 129,074,477 | |
ICFR Auditor Attestation Flag | true | | |
Entity File Number | 001-37906 | | |
Entity Incorporation, State or Country Code | DE | | |
Entity Address, Address Line One | 85 Dan Road | | |
Entity Address, City or Town | Canton | | |
Entity Address, Postal Zip Code | 02021 | | |
Entity Tax Identification Number | 98-1329150 | | |
City Area Code | 781 | | |
Local Phone Number | 575-0775 | | |
Auditor Name | RSM US LLP | | |
Auditor Firm ID | 49 | | |
Auditor Location | Boston, Massachusetts | | |
Amendment Description | This Amendment No. 1 to Form 10-K (this “Amendment”) amends the Annual Report on Form 10-K for the fiscal year ended December 31, 2021 originally filed on March 1, 2022 (the “Original Filing”) by Organogenesis Holdings Inc. (“ORGO”, the “Company”, “we”, or “us”). We are filing this Amendment to present the information required by Part III of Form 10-K as we will not file our definitive proxy statement within 120 days of the end of our fiscal year ended December 31, 2021. Except as described above, this Amendment does not amend, update or change any other items or disclosures in the Original Filing, and accordingly, should be read in conjunction with the Original Filing. As required by Rule 12b-15 under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by our principal executive officer and our principal financial officer are filed as exhibits to this Amendment under Item 15 of Part IV hereof. | | |